Cite Filings / XFOR / 0001072613-25-000643

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

X4 Pharmaceuticals, Inc Filed 2025-08-15 Acc 0001072613-25-000643

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-10-29 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-15 SCHEDULE 13D/A Beneficial Ownership Report
2025-08-14 3 Initial Statement of Ownership
2025-08-14 3 Initial Statement of Ownership
2025-08-14 4 Executive Chairman acquired 289,881 shares (grant or award)
2025-08-14 4 Chief Financial Officer acquired 193,254 shares (grant or award)
2025-08-14 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…